Dr. Lal Path Labs Ltd. has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

LALPATHLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.2%1-day move

₹1394.20

prior close

₹1409.90

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.2-1.2-0.7-0.8-1.2+2.8+1.5+0.7+1.5+4.7+10.0+18.2+12.2+21.4

Up moveDown movePending

AI summary

Dr. Lal Path Labs has submitted a compliance certificate for Q4 FY26 (quarter ended March 31, 2026) under SEBI Regulation 74(5). The certificate from their Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirms that no dematerialization requests were received for processing during the quarter. The RTA also noted that the company has no physical shares outstanding, meaning all shares are already in demat form. This is a routine quarterly regulatory filing required under SEBI regulations.

Likely market impact

This filing has no direct impact on shareholders or stock price as it is a standard regulatory compliance confirmation with no material information about the company's operations or financials.